Post-artesunate Delayed Hemolysis in Patients With Severe Malaria in the United States-April 2019 Through July 2021.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America(2023)

引用 2|浏览1
暂无评分
摘要
PADH is an uncommon and self-limiting adverse event in many cases; weekly monitoring of hemoglobin and hemolytic markers may identify cases requiring intervention in a timely manner.
更多
查看译文
关键词
adverse effects,intravenous artesunate,post-artesunate delayed hemolysis,safety,severe malaria
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要